Form 4: HCA Director Frist III Reports Major Share Reorganization

HCA Healthcare Director and 10% Owner Thomas F. Frist III reported a significant internal share reorganization involving Frisco Holding II, exchanging 36.6 million shares for 36.5 million newly issued shares.

Summary

• Thomas F. Frist III, a Director and 10% Owner of HCA Healthcare, Inc., reported a transaction involving a significant number of shares.
• On February 6, 2026, Frisco Holding II, an entity associated with the Frist family, disposed of 36,629,188 shares of HCA Common Stock.
• Concurrently, Frisco Holding II acquired 36,557,141 newly issued shares from HCA Healthcare, Inc. in an exchange.
• This transaction, along with Frisco's conversion to a partnership for tax purposes, constituted a reorganization under Section 368(a) of the Internal Revenue Code.
• The transaction was exempt from certain registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3.
• Frist III disclaims beneficial ownership of the shares held by Frisco Holding II and Hercules Holding II, except to the extent of his pecuniary interest, which includes direct and indirect interests through trusts for his children and spouse.
• Frist III also holds 14,817 restricted share units, payable in shares upon his departure as a director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for HCA Healthcare's operational performance. It represents an internal restructuring of a major shareholder's holdings, not a change in the company's fundamentals or a market-driven sale/purchase.

Positives

• The transaction is part of a tax-exempt reorganization, indicating a structured approach to managing significant family holdings.
• The transaction was exempt from certain regulatory requirements, suggesting compliance with specific rules for such reorganizations.

Industry Context

StockSavvy.ai notes that such reorganizations of significant insider holdings are common among long-standing, family-affiliated major shareholders, often driven by estate planning, tax efficiency, or changes in investment structure. This particular filing reflects an internal restructuring of the Frist family's substantial stake in HCA Healthcare, rather than a change in their overall investment thesis or a market-driven transaction.

Related Party Transactions

• The transaction involves Frisco Holding II and Hercules Holding II, entities held by a private investor group including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr., making them related parties to Thomas F. Frist III, a director and 10% owner.
• The reorganization involved an exchange of shares between Frisco Holding II and HCA Healthcare, Inc.

Stakeholder Impact

• Shareholders: The reorganization of a significant insider's holdings does not directly impact the company's operations or financial health. It clarifies the structure of a major shareholder's ownership.
• Employees, Customers, Suppliers, Creditors: No direct impact is indicated by this filing.

Key Dates

Recommendation

This Form 4 details an internal reorganization of shares by a significant insider and 10% owner, Thomas F. Frist III, involving entities tied to the Frist family. It is a technical transaction related to tax and ownership structure rather than a reflection of HCA Healthcare's operational performance or a change in the insider's investment conviction. As such, it provides no new information that would warrant a change in an investor's current 'hold' position on HCA stock.

Keywords

HCA Healthcare, Thomas F. Frist III, SEC Form 4, Insider Transaction, Share Reorganization, Beneficial Ownership, Frisco Holding II, Hercules Holding II, Director, 10% Owner